[go: up one dir, main page]

WO2005060437A3 - Combinaisons de compositions et procedes de traitement, de prevention, de suppression et d'inhibition de la douleur - Google Patents

Combinaisons de compositions et procedes de traitement, de prevention, de suppression et d'inhibition de la douleur Download PDF

Info

Publication number
WO2005060437A3
WO2005060437A3 PCT/US2004/036187 US2004036187W WO2005060437A3 WO 2005060437 A3 WO2005060437 A3 WO 2005060437A3 US 2004036187 W US2004036187 W US 2004036187W WO 2005060437 A3 WO2005060437 A3 WO 2005060437A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibitor
reversing
treating
preventing
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/036187
Other languages
English (en)
Other versions
WO2005060437A2 (fr
Inventor
Daniela Salvemini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metaphore Pharmaceuticals Inc
Original Assignee
Metaphore Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metaphore Pharmaceuticals Inc filed Critical Metaphore Pharmaceuticals Inc
Publication of WO2005060437A2 publication Critical patent/WO2005060437A2/fr
Anticipated expiration legal-status Critical
Publication of WO2005060437A3 publication Critical patent/WO2005060437A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/32—Tin compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une combinaison de compositions destinées au traitement, à la prévention, à la suppression ou à l'inhibition de la douleur, dans laquelle au moins une composition comprend un inhibiteur de nitration. En outre, l'invention concerne un procédé dans lequel l'inhibiteur de nitration est choisi dans le groupe constitué d'un inhibiteur de système de génération de SO, d'un capteur de SO, d'un inhibiteur de NOS, d'un inhibiteur de système de génération de NO, d'un capteur de NO, d'un inhibiteur de système de génération de peroxynitrite, d'un capteur de peroxynitrite, et de n'importe quelle combinaison de ceux-ci. De préférence, l'inhibiteur de nitration est combiné avec un inhibiteur de douleur. Cet inhibiteur de douleur consiste de préférence en un opioïde.
PCT/US2004/036187 2003-10-31 2004-10-31 Combinaisons de compositions et procedes de traitement, de prevention, de suppression et d'inhibition de la douleur Ceased WO2005060437A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51616503P 2003-10-31 2003-10-31
US60/516,165 2003-10-31

Publications (2)

Publication Number Publication Date
WO2005060437A2 WO2005060437A2 (fr) 2005-07-07
WO2005060437A3 true WO2005060437A3 (fr) 2013-07-11

Family

ID=34710033

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/036187 Ceased WO2005060437A2 (fr) 2003-10-31 2004-10-31 Combinaisons de compositions et procedes de traitement, de prevention, de suppression et d'inhibition de la douleur

Country Status (1)

Country Link
WO (1) WO2005060437A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
US9102636B2 (en) * 2010-03-10 2015-08-11 Galleon Pharmaceuticals, Inc. Analgesic compounds, compositions, and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO2005060437A2 (fr) 2005-07-07

Similar Documents

Publication Publication Date Title
WO2004105700A3 (fr) Composes, procedes et compositions pharmaceutiques destines a l'inhibition de la parp
EG24978A (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment.
EP1628530B8 (fr) Procedes et compositions pour la prevention et le traitement de la sepsie
WO2005023761A3 (fr) Inhibiteurs des cytokines
WO2003077867A3 (fr) Compositions a base de chlorhydrate de naltrexone
WO2004096122A3 (fr) Procedes de traitement de la douleur par administration d'un antagoniste du facteur de croissance du nerf et d'un analgesique opioide et compositions les contenant
WO2002032874A3 (fr) Composes heterocycliques substitues pour le traitement de resistance a des medicaments multiples
WO2006073973A3 (fr) Nouveaux dérivés de benzylamine en tant qu'inhibiteurs de cetp
WO2004021990A3 (fr) Compositions et kits pour l'elimination de composes irritants de surfaces corporelles
WO2000077206A3 (fr) Promoteur du gene de la myostatine et methode pouvant inhiber l'activation dudit promoteur
EP2319847A3 (fr) Composés de diazabenzo[de]anthracene-3-one et méthodes pour l'inhibition de PARP
WO2004084943A8 (fr) Utilisation d'antagonistes de la ghrelin ou du recepteur de la ghrelin pour traiter l'inflammation intestinale
WO2004043456A8 (fr) Inhibiteurs d'absorption du cholesterol pour le traitement de la demyelination
WO2004049907A3 (fr) Compositions et méthodes de traitement de greffons
WO2005027780A3 (fr) Enveloppe auto-adhesive modifiee
WO2004032908A3 (fr) Methode d'inhibition de l'angiogenese
WO2004084842A3 (fr) Inhibiteurs de cathepsine s
WO1998036730A3 (fr) Compositions de traitement de l'acne rosacee
WO2005023191A3 (fr) Procedes et compositions associes aux produits terminaux de la glycation avancee pour le traitement de la lesion glomerulaire
WO2004087066A3 (fr) Inhibiteurs de hif-1
WO2005000208A3 (fr) Therapie combinee pour le traitement des neoplasmes
WO2001087287A3 (fr) Composes actifs sur le plan pharmaceutiques et procedes d'utilisation
WO2005041904A3 (fr) Inhibiteurs de la protease de coronavirus et procedes de leur utilisation
UA83203C2 (uk) Тіазол-(бі)циклоалкілкарбоксаніліди, засіб на їх основі та застосування для боротьби з небажаними мікроорганізмами
WO2001028493A3 (fr) Inhibiteurs a petite molecule de la necrose

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct app. not ent. europ. phase